Insider · CIK 0001188728
Stephen C McCluski
Files at IMGN (ImmunoGen, Inc.), MNRO (MONRO, INC.). First filing -, latest -.
In brief
Stephen C McCluski files SEC Form 4 as director at IMGN (ImmunoGen, Inc.), and also at MNRO (MONRO, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Stephen C McCluski has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | MNRO MONRO, INC. | AGrant or award Common Stock | +11,149 | $0.00 | $0 | 43,077 | Aug 12, 2026 |
| Aug 12, 2025 | MNRO MONRO, INC. | AGrant or award Restricted Stock Award10b5-1 | +8,306 | $0.00 | $0 | 31,928 | Aug 13, 2025 |
| Aug 13, 2024 | MNRO MONRO, INC. | AGrant or award Restricted Stock Award | +4,937 | $0.00 | $0 | 23,622 | Aug 15, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Restricted Stock Unitderivative | -13,090 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Deferred Share Unitderivative | -105,458 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -18,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -18,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -50,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -44,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -44,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,597 | - | - | 0 | Feb 12, 2024 |
Questions about Stephen C McCluski
Answered from the filings on this page, as of the latest one.
Is Stephen C McCluski buying or selling?
Stephen C McCluski has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Stephen C McCluski's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen C McCluski has 0.
Where does Stephen C McCluski file Form 4?
Stephen C McCluski has filed Form 4 at IMGN (ImmunoGen, Inc.); MNRO (MONRO, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.